Seminars in Oncology
Volume 30, Issue 1 , Pages 79-85, February 2003

Targeting lethal minimal residual disease in small cell lung cancer☆

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, NY.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Address reprint requests to Lee M. Krug, MD, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021.

PII: S0093-7754(03)70045-1

doi:10.1053/sonc.2003.50018

Seminars in Oncology
Volume 30, Issue 1 , Pages 79-85, February 2003

Article Tools